Ophthalmology Times - Ophthalmology news, articles, and events
WEBEyeCon 2024: Key takeaways for enhanced patient care from Day 1. This Week in Ophthalmology: Week of September 22, 2024. EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice. Eyecon 2024: Thyroid Eye Disease in focus. Retina Society 2024: A …
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 — The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 — Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 — Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
News - Ophthalmology Times
WEBEyeCon 2024: Current trends in the treatment of common retinal diseases. September 29th 2024. Lloyd Clark, MD, discusses the evolution and current practices in the treatment of common retinal diseases such as age-related macular degeneration, diabetic macular edema, and retinal vein occlusion.
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
WEBOct 18, 2023 — Orasis Pharmaceuticals announced the FDA has approved pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for the treatment of presbyopia in adults. The company announced it expects to have pilocarpine hydrochloride ophthalmic solution commercially available in the U.S. in the first half of 2024 …
Advancements in ophthalmology: A comprehensive look at the …
WEBDec 12, 2023 — It’s safe to say 2024 will have to work extra hard to top the year 2023. Overall, 2023 emerges as a landmark year in the realm of ophthalmology, marked by an extraordinary 12 FDA approvals. The approval of Apellis' pegcetacoplan injection for geographic atrophy marked a significant milestone, …
Dealing with positive and negative dysphotopsias
WEBOct 4, 2019 — Positive dysphotopsias are most often characterized by persistent bright rings, flares, arcs, halos, and flashes that most often appear when light is coming into. the eye from the side, such as the oncoming headlights of another vehicle. The long term incidence may be as high as 1.5% and can vary greatly by IOL type, material, and design.
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 — Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in …
Biometry 101: Capturing the accurate power - Ophthalmology Times
WEBFeb 17, 2022 — Biometry 101: Capturing the accurate power. Proper measurement of the eye is key to predicting lens strength. Reviewed by Julie Schallhorn, MD, MS. Knowledge of the optics of the eye is essential in order to have an understanding of biometry, according to Julie Schallhorn, MD, MS, an associate professor of ophthalmology at the University of ...